Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Fiem Industries Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

The company is currently working on a pipeline of RFQs (Request for Quotations) worth approximately INR 700 crores in the 4-wheeler segment. Key concall…

13 Jun 2026

Ion Exchange (India) Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

The company’s order intake in the engineering segment has been quite healthy, with a 40% increase compared to the last full financial year. Key concall…

13 Jun 2026

Suprajit Engineering Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

SCD (Suprajit Controls Division)预计实现10%以上增长,并计划扩充产能,以满足新增订单。 . Key concall takeaways from Suprajit Engineering Ltd's Q4 FY26 earnings call — and how it ranks…

13 Jun 2026

Ahluwalia Contracts (India) Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Order inflow in Q4 FY26 was INR 4,300 crores. Key concall takeaways from Ahluwalia Contracts (India) Ltd's Q4 FY26 earnings call — and how it ranks against…

13 Jun 2026

Ashapura Minechem Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Market share growth in bentonite (~35% domestic, >40% export share) with ongoing new product development for oil & gas and foundry sectors. Key concall…

13 Jun 2026

Max Estates Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Residential pipeline stands at over INR17,200 crores. Key concall takeaways from Max Estates Ltd's Q4 FY26 earnings call — and how it ranks against sector…

13 Jun 2026

Aarti Pharmalabs Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Rs.700-770 Crores) in FY2027, recovering from previous degrowth due to inventory and price erosion issues. Key concall takeaways from Aarti Pharmalabs Ltd's Q4…

13 Jun 2026

Transrail Lighting Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

The company has a strong order book of INR16,000 crores unexecuted orders and plans new order intake of INR10,000 to 11,000 crores yearly to support growth…

13 Jun 2026

Sky Gold & Diamonds Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Capacity utilization stands at 55% (650 kg against 1.2-ton capacity) with no immediate capacity constraints until 2028 March; plans include asset-light models…

13 Jun 2026

Redtape Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Apparel contributes 34% of turnover but segment-wise margins are not disclosed. Key concall takeaways from Redtape Ltd's Q4 FY26 earnings call — and how it…

13 Jun 2026

Transport Corporation of India Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

The budget for ships this year is about ₹237 crores, which includes advance payments for the two ships and the potential third ship. Key concall takeaways from…

13 Jun 2026

Relaxo Footwears Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Revenue growth was reported at 8.1% YoY in Q4 FY26, with positive momentum seen in Q4 and continuing into early FY27. Key concall takeaways from Relaxo…

13 Jun 2026

Praj Industries Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

800-900 crores based on the current pipeline (Page 11). Key concall takeaways from Praj Industries Ltd's Q4 FY26 earnings call — and how it ranks against…

13 Jun 2026

Mishra Dhatu Nigam Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Capex of around INR 1,000 crores planned over next 3 years to improve downstream operations efficiency and increase production capacity. Key concall takeaways…

13 Jun 2026

Jeena Sikho Lifecare Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Product sales grew by INR 3 crores last month; repeat business in hospital at 26%, product side 34%. Key concall takeaways from Jeena Sikho Lifecare Ltd's Q4…

13 Jun 2026

ISGEC Heavy Engineering Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Order book remains healthy with INR 7,000 crores opening order book excluding cancelled orders; new order bookings of INR 1,400 crores in first two months of…

13 Jun 2026

RHI Magnesita India Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Revenues grew 9% YoY to INR 4,000 crores in FY '26; shipments up 5% to 523 kilotons. Key concall takeaways from RHI Magnesita India Ltd's Q4 FY26 earnings call…

13 Jun 2026

Indian Metals & Ferro Alloys Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Long-term contracts to cover approximately 70-75% of sales, with the balance via spot sales to repeat customers. Key concall takeaways from Indian Metals &…

13 Jun 2026

V2 Retail Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Plans to add 50%-60% new retail area each year, doubling down on expansion while maintaining strong sales per square feet (SSG) growth. Key concall takeaways…

13 Jun 2026

Marksans Pharma Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Capacity utilization currently about 50-55%, with spare capacity to support growth before expansion. Key concall takeaways from Marksans Pharma Ltd's Q4 FY26…

13 Jun 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access